Big Pharma’s Loss Is Clean Ingredients’ Gain

A Merck chemist who spent 20 years targeting disease with precision molecules is now letting nature lead the molecular blueprint.

A Merck chemist who spent 20 years targeting disease with precision molecules is now letting nature lead the molecular blueprint.